foto london banner.jpg

Something Powerful

Tell The Reader More

The headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.

Remember:

  • Bullets are great
  • For spelling out benefits and
  • Turning visitors into leads.

SurgaColl’s £3.1m Series A investment to drive nex...

Key learnings: SurgaColl announced the completion of a £3.1 million Series ...

Read More

Carmell Therapeutics advances plasma-based product...

Key learnings: Carmell™ Therapeutics closed its Series B round in June 2017...

Read More

STORM Therapeutics leads the way in RNA epigenetic...

Key learnings: STORM Therapeutics is developing small molecule inhibitors o...

Read More

Stent Tek sees development ramp up following Serie...

Key learnings: Medical device company Stent Tek successfully closed its Ser...

Read More

Winner’s spotlight: Verona Pharma

Key learnings: Verona Pharma won the Life Science IPO of the Year Award at ...

Read More

Transatlantic investment: barriers and benefits fo...

On Monday 5 February 2018, leading investors will come together in London t...

Read More

Investorview: Proactively Bridging The Early Stage...

Sinclair Dunlop, Managing Partner at Epidarex Capital Venture capital firm ...

Read More

Boult Wade Tennant: Aligning patent strategy and c...

Key learnings: Boult Wade Tennant provides international patent and trade m...

Read More

Investorview: Dr Z Haroon on Julz Co’s recent inve...

Julz Co focuses on healthcare investments across the US, Europe, and Asia-P...

Read More

Garry Kasparov: Reframing the conversation on AI a...

Key learnings: On 14 November, former world chess champion, business speake...

Read More

Ali Mortazavi: On genomic data and pivotal moments...

On 14 November, RNA therapeutics company Silence Therapeutics hosted a pane...

Read More

Dr Annalisa Jenkins: On RNAi, her new chairmanship...

In October 2017, RNA therapeutics company Silence Therapeutics appointed Dr...

Read More

Add Your Response